Is the effect of coping styles disease specific? Relationships with emotional distress and quality of life in acquired brain injury and multiple sclerosis

Brands, Ingrid; Bol, Yvonne; Stapert, Sven; Köhler, Sebastian; Heugten, Caroline van

doi:10.1177/0269215517718367

Cited by 23 publications

(20 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ing and anxiety in the final analyses. The importance of coping in quality of life and in anxiety is stated in multiple MS studies 18,24,49. Our study confirms this pattern and is the first MS study on anxiety that includes demographic, disease-related and psychological variables in a multivariable analysis, including comprehensive cognitive functioning.…”

supporting

confidence: 85%

“…The importance of coping in quality of life and in anxiety is stated in multiple MS studies. 18,24,49 More specifically, a greater reliance on emotion-focused coping strategies is related to poor psychosocial adjustment, depression and anxiety. 49 Lack of correlations between these disease-related variables, together with the strong relation between anxiety, depression and cognitive complaints, can possibly be explained by coping as a moderating variable.…”

Section: Ta B L E 2 Means and Standard Deviations Of Psychological Qumentioning

confidence: 99%

“…Correlations in other studies might be explained by the use of the State-Trait Anxiety Inventory (STAI) instead of the HADS 21 and the use of other neuropsychological tests,21,22 or, again, failure to account for other contributors in a single model.The importance of psychological factors has been stated in earlier research on quality of life in MS patients, which demonstrates that fatigue, depression, anxiety and cognitive impairment are more important contributors of quality of life than physical symptoms and neurological impairment [3][4][5]. More specifically, a greater reliance on emotion-focused coping strategies is related to poor psychosocial adjustment, depression and anxiety 49. We suggest it is not the disease-specific factors that contribute to anxiety, but how well patients adjust to the disease.…”

mentioning

confidence: 97%

See 2 more Smart Citations

Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints

et al. 2019

Self Cite

View full text Add to dashboard Cite

Objectives: Multiple sclerosis (MS) patients suffer from high levels of anxiety.However, it is unclear which factors are related to anxiety, since study results are inconsistent, and the associated factors have not been examined comprehensively.In this study, we investigated the demographic, disease-related and psychological factors associated with anxiety in MS patients. Materials and methods:Cross-sectional data of 119 MS patients were used. Anxiety and depressive symptoms (Hospital Anxiety and Depression Scale), fatigue (Fatigue Severity Scale), cognitive complaints (Cognitive Failures Questionnaire) and cognitive functioning (Wisconsin Card Sorting Test, Controlled Oral Word Association Test, Letter Digit Substitution Test, Concept Shifting Test, Wechsler Memory Test Faces and the Dutch version of the California Verbal Learning Test) were measured.Bivariate and multivariable regression analyses were conducted to test the associations between anxiety and potential contributing factors.Results: In this sample, 42% of the MS patients had clinically significant levels of anxiety, defined by a score ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS). A significant correlation was found between anxiety and depressive symptoms, fatigue, cognitive complaints and psychiatric history. In the multivariable analysis, only depressive symptoms and cognitive complaints remained significantly related to anxiety.Conclusions: Anxiety is common in MS patients and most strongly related to psychological factors. This knowledge can be taken into account when treating patients with MS. Further research is needed using longitudinal designs and incorporating other factors known to influence anxiety, such as coping, negative affectivity and social support. K E Y W O R D Sanxiety, cognition, contribute, depression, multiple sclerosis, psychological S U PP O RTI N G I N FO R M ATI O NAdditional supporting information may be found online in the Supporting Information section.

show abstract

supporting

confidence: 85%

Section: Ta B L E 2 Means and Standard Deviations Of Psychological Qumentioning

confidence: 99%

mentioning

confidence: 97%

See 1 more Smart Citation

Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Specific coping styles (e.g. emotion-oriented coping) have even been reported to have an effect on disease severity, for example in multiple sclerosis (Brands et al 2017). For CSC, several mostly small-sized studies have reported an association between severe psychosocial stressful events and the onset of disease, with one study describing this association especially in patients with poor coping mechanisms (Conrad et al 2000;Spahn et al 2004;Lahousen et al 2016).…”

Section: Introductionmentioning

confidence: 99%

Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy

Haalen

Dijk

Andela

et al. 2018

Acta Ophthalmologica

View full text Add to dashboard Cite

Purpose ‘Type A’ behavioural characteristics and psychosocial stress have traditionally been associated with chronic central serous chorioretinopathy (cCSC). However, a characteristical personality profile could not be identified in these patients and the presumed association with stress is subject to controversy, due to a lack of convincing studies using validated measuring instruments. In this study, we aimed to assess maladaptive personality traits, psychological morbidity and coping strategies in patients with cCSC, in order to identify potentially modifiable psychosocial aspects which could be used in support to current standard treatment. Methods A cross‐sectional study in a cohort of 86 patients with cCSC using validated questionnaires. Findings were compared to both Dutch population reference data and reference data from patients treated for Cushing's disease. Results Maladaptive personality traits were not more prevalent in patients with cCSC than in the general population, and psychological morbidity was not increased. Patients with cCSC were shown to make more use of passive coping, active coping and seeking social support. Interestingly, personality, psychological morbidity and coping characteristics of patients with cCSC were more comparable to features of patients treated for Cushing's disease than to population‐based data. Conclusion Maladaptive personality traits such as type A behavioural characteristics are not more prevalent in patients with cCSC. Patients with cCSC make more use of certain coping strategies, which could be addressed by psychosocial care to improve self‐management. Further research is needed establish whether the course of disease can be improved by altering coping and reducing ‘stress’.

show abstract

“…LiSAT-9 is a potential life satisfaction instrument of choice in studies assessing quality of life in patients with MS, acquired brain or spinal cord injury where spasticity is a major concern [24, 34]. A decreased health-related quality of life in the elderly due to the presence of comorbid diseases, impaired mobility, social isolation, depressed feelings and moods among others has been studied [35].…”

Section: Discussionmentioning

confidence: 99%

Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms

Berntsson

Gauffin

Melberg

et al. 2019

Stereotact Funct Neurosurg

View full text Add to dashboard Cite

Background: Intrathecal baclofen (ITB) treatment is considered a powerful tool in the management of severe spasticity in neurological conditions such as multiple sclerosis, cerebral palsy, and traumatic spinal cord and brain injury. Objectives: The objective of this study was to assess the effectiveness of the ITB in patients with inherited ataxia suffering from severe painful spasms and/or spasticity. Method: A total of 5 patients with spinocerebellar ataxia 3 or 7 or Friedreich’s ataxia were included in this observational multicenter study. The patients were interviewed and completed outcome measures assessing pain (The Brief Pain Inventory), fatigue (Fatigue Severity Scale), and life satisfaction (LiSAT-9) before and 1 year after the treatment. Spasticity (Modified Ashworth Scale) and spasm frequency (SPFS) were measured objectively for each patient. Results: The mean treatment time was 1.9 years. Evaluation of established standard forms revealed symptomatic relief from spasticity, spasms, pain, and fatigue in addition to improved body posture, sleep, and life satisfaction after ITB treatment. Conclusions: We report the potential beneficial effects of ITB treatment in patients with inherited ataxia who also suffer from spasticity/spasms. ITB treatment indication in neurological disorders allows for extension to the treatment of spasticity/ spasms in patients with hereditary ataxia.

show abstract

Is the effect of coping styles disease specific? Relationships with emotional distress and quality of life in acquired brain injury and multiple sclerosis

Cited by 23 publications

References 45 publications

Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints

Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints

Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy

Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms

Contact Info

Product

Resources

About